CA 125 in the monitoring of response to chemotherapy of ovarian carcinoma
- 1 January 1988
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 41 (S3) , 68-70
- https://doi.org/10.1002/ijc.2910410814
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Pros and cons of gynecologic tumor markersCancer, 1987
- CA125 as a serum marker for poor prognosis in ovarian malignanciesGynecologic Oncology, 1987
- Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1985
- Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour markerBritish Journal of Cancer, 1984
- Second-look laparotomy in ovarian cancerGynecologic Oncology, 1982
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981
- Second-look operations in ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1980